Drugmakers, including Gilead Sciences Inc, Bristol-Myers Squibb Co, and Biogen Inc have hiked their U.S. list prices on more than 50 drugs, according to data analyzed by 3 Axis Advisors, a healthcare research firm. On Tuesday, there were media reports… Read More ›
Jonathan Symonds is HSBC’s deputy chairman. His appointment to the post, still under negotiations, will be subject to approval from banking regulators. Bloomberg has reported citing a source familiar with the matter at hand as saying, GlaxoSmithKline Plc is in… Read More ›
The drugmaker has begun the process of searching for Philip Hamptonwill’s successor. On Monday, drugmaker GlaxoSmithKline plc stated, Philip Hamptonwill, its chairman will be stepping down from his role. Hamptonwill has been GlaxoSmithKline’s chairman for more than three and a… Read More ›
With Reckitt Benckiser out of the race, it is advantage GlaxoSmithKline Plc. Reckitt Benckiser Group, a British consumer goods group, has withdrawn from discussions with Pfizer Inc over buying its consumer healthcare business. According to sources familiar with the matter… Read More ›
manageria.biz 